Christopher Cleary's most recent trade in Orchestra BioMed Holdings Inc was a trade of 30,742 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 30,742 | 30,742 | - | - | Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 10,155 | 10,155 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") |